Evgeny Viktorovich Sadovski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Evgeny Viktorovich Sadovski has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Ekaterina Mikhailovna Stakhneva
Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
12 shared publications - Yuliya Igorevna Ragino
Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
12 shared publications - Elena Vladimirovna Kashtanova
Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
10 shared publications - Yana Vladimirovna Polonskaya
Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
10 shared publications - Viktoriya Shramko
Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
8 shared publications - Alexander Mikhailovich Chernyavskii
National Medical Research Center named after Academician E.N. Meshalkin; Novosibirsk State Medical University
5 shared publications
Latest Publications
- 30 June 2026
- Published by The Institute of Internal and Preventive Medicine in Ateroscleroz
- Vol. 22 (2)
Changes in the proteomic profile of blood serum in coronary atherosclerosis and abdominal obesity
Background – to study the relationship of blood proteins with abdominal obesity in patients with coronary atherosclerosis by quantitative proteomic analysis. Methods. The study involved patients with coronary atherosclerosis ( n = 36), with an average age of 57 ± 7 years. The research material is blood serum. Protein concentrations in serum samples were determined using the PeptiQuant Plus Proteomics Kit. The identification of protein fractions was carried out by monitoring multiple reactions on a Q-TRAP 6500 mass spectrometer combined with a liquid chromatograph. Results. Mass spectrometric identification revealed lower concentrations of proteins in blood serum samples from patients with coronary atherosclerosis and abdominal obesity: serum albumin, apolipoproteins A (I, IV), C (I, III, IV), L1, thrombospondin 1, PAI 1, coagulation factors (X, XII), complement factor H, fibronectin, CD5 antigenlike protein, phospholipid-transferring protein, gelsolin and osteonectin, compared with those without AO. The differences were considered significant at p < 0.05. In patients with coronary atherosclerosis, a correlation was found between AO and osteonectin (r = –0.603; p = 0.0001). In addition, the presence of AO is associated with the concentration of osteonectin (B = –0,087; Exp(B) = 0,916; ДИ 0,843– 0,996; p = 0,039) and gelsolin (B = –0,092; Exp(B) = 0,912; ДИ 0,839–0,991; p = 0,029). Conclusions. In this study, we found a decrease in blood concentrations of proteins associated with the inflammatory process, lipid metabolism, adaptive immune responses in coronary atherosclerosis and AO. In addition, in coronary atherosclerosis, the reverse association of AO with gelzolin and osteonectin, a well-known marker of arterial calcification, was revealed. These results can serve as a basis for further research, as well as for a better understanding of the effect of AO on coronary atherosclerosis.
- 30 June 2026
- Published by The Institute of Internal and Preventive Medicine in Ateroscleroz
- Vol. 22 (2)
Changes in the proteomic profile of blood serum in coronary atherosclerosis and abdominal obesity
Background – to study the relationship of blood proteins with abdominal obesity in patients with coronary atherosclerosis by quantitative proteomic analysis. Methods. The study involved patients with coronary atherosclerosis ( n = 36), with an average age of 57 ± 7 years. The research material is blood serum. Protein concentrations in serum samples were determined using the PeptiQuant Plus Proteomics Kit. The identification of protein fractions was carried out by monitoring multiple reactions on a Q-TRAP 6500 mass spectrometer combined with a liquid chromatograph. Results. Mass spectrometric identification revealed lower concentrations of proteins in blood serum samples from patients with coronary atherosclerosis and abdominal obesity: serum albumin, apolipoproteins A (I, IV), C (I, III, IV), L1, thrombospondin 1, PAI 1, coagulation factors (X, XII), complement factor H, fibronectin, CD5 antigenlike protein, phospholipid-transferring protein, gelsolin and osteonectin, compared with those without AO. The differences were considered significant at p < 0.05. In patients with coronary atherosclerosis, a correlation was found between AO and osteonectin (r = –0.603; p = 0.0001). In addition, the presence of AO is associated with the concentration of osteonectin (B = –0,087; Exp(B) = 0,916; ДИ 0,843– 0,996; p = 0,039) and gelsolin (B = –0,092; Exp(B) = 0,912; ДИ 0,839–0,991; p = 0,029). Conclusions. In this study, we found a decrease in blood concentrations of proteins associated with the inflammatory process, lipid metabolism, adaptive immune responses in coronary atherosclerosis and AO. In addition, in coronary atherosclerosis, the reverse association of AO with gelzolin and osteonectin, a well-known marker of arterial calcification, was revealed. These results can serve as a basis for further research, as well as for a better understanding of the effect of AO on coronary atherosclerosis.
- Open Access
- 21 January 2025
- Published by Arterialnaya Gipertenziya in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
- Vol. 30 (5) , 477-486
The relationship between metabolic hormone levels and the prevalence of hypertension in people under 45 years of age
Among the various factors potentially involved in the pathogenesis of cardiovascular diseases, arterial hypertension (HTN), in the structure of which the proportion of young people increases, is still the most common risk factor for the development of serious cardiovascular complications. The development of structural and functional disorders associated with HTN is accompanied by an increase or decrease in markers of metabolic disorders. Objective. Тo study the prevalence of HTN in young people of working age and childbearing age, depending on the levels of metabolic hormones. Design and methods. The study included 1,340 people from the Novosibirsk population sample aged 25–44 years. HTN was diagnosed in case of the average systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg. The levels of amylin, C-peptide, ghrelin, glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1), glucagon, insulin, pancreatic polypeptide (PP), and peptide YY (PYY) were determined by multiplex analysis. Results. In the quartile with the highest values of amylin, C-peptide, GIP, GLP-1 and PP, the prevalence of HTN is significantly higher compared to Q1. In the group of HTN patients, the levels of amylin, C-peptide, ghrelin, GIP, GLP-1, insulin and PP were 2,4 (p < 0,0001), 1,4 (p < 0,0001), 1,3 (p = 0,001), 1,3 (p = 0,003), 1,6 (p = 0,001), 1,2 (p = 0,002) and 1,4 (p = 0,006) times higher, respectively, in comparison with persons without HTN. Conclusions. The prevalence of HTN is associated with high values of amylin, ghrelin, glucagon, insulin and C-peptide. The chance of HTN increases starting from the second quartile of amylin and increases with each quartile.
- 21 January 2025
- Published by Arterialnaya Gipertenziya in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
- Vol. 30 (5) , 477-486
Open AccessThe relationship between metabolic hormone levels and the prevalence of hypertension in people under 45 years of age
Among the various factors potentially involved in the pathogenesis of cardiovascular diseases, arterial hypertension (HTN), in the structure of which the proportion of young people increases, is still the most common risk factor for the development of serious cardiovascular complications. The development of structural and functional disorders associated with HTN is accompanied by an increase or decrease in markers of metabolic disorders. Objective. Тo study the prevalence of HTN in young people of working age and childbearing age, depending on the levels of metabolic hormones. Design and methods. The study included 1,340 people from the Novosibirsk population sample aged 25–44 years. HTN was diagnosed in case of the average systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg. The levels of amylin, C-peptide, ghrelin, glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1), glucagon, insulin, pancreatic polypeptide (PP), and peptide YY (PYY) were determined by multiplex analysis. Results. In the quartile with the highest values of amylin, C-peptide, GIP, GLP-1 and PP, the prevalence of HTN is significantly higher compared to Q1. In the group of HTN patients, the levels of amylin, C-peptide, ghrelin, GIP, GLP-1, insulin and PP were 2,4 (p < 0,0001), 1,4 (p < 0,0001), 1,3 (p = 0,001), 1,3 (p = 0,003), 1,6 (p = 0,001), 1,2 (p = 0,002) and 1,4 (p = 0,006) times higher, respectively, in comparison with persons without HTN. Conclusions. The prevalence of HTN is associated with high values of amylin, ghrelin, glucagon, insulin and C-peptide. The chance of HTN increases starting from the second quartile of amylin and increases with each quartile.
- 3 July 2024
- Published by The Institute of Internal and Preventive Medicine in Ateroscleroz
- Vol. 20 (2)
Abdominal obesity and levels of inflammatory markers and adipokines in young people with hypertension
Objective: to investigate pro- and anti-inflammatory markers and blood adipokines in young people with arterial hypertension (AH) on the background of abdominal obesity (AO). Materials and methods. 510 people were included in the study, of which 257 people with hypertension, of which 164 were with AO. In the control group (without AH) there were 253 people of comparable gender and age, with AO – 101 people. The content of adipsin, lipocalin-2, resistin, TNF-α, IL-6, IL-8, IL-10, IL-17a, IL-17e, IL-17f was determined in all blood by multiplex analysis. Statistical processing was carried out in the SPSS 13.0 program. Results. When comparing the studied parameters in the studied groups, statistically significant differences were obtained for lipocalin-2, resistin, adipsin, IL-6 and IL-17a, all these indicators were higher in the group with hypertension. There was no difference between the control and the group with hypertension in other biomarkers. There was no effect of AO on the level of the studied markers in the control group. For the main group, the difference between the subgroups with and without AO was obtained for lipocalin. Also, the systolic pressure level was significantly higher in the group with AO. Correlation analysis revealed a weak association of systolic and diastolic blood pressure with TNF-α, IL-6, adipsin, lipocalin-2, resistin and waist circumference. the association of body mass index with lipocalin-2, IL-6 and TNF-α (p < 0.01), a strong association of adipsin, lipocalin-2, resistin with TNF-α and IL-17a (p < 0.01). Conclusion. Of the markers we studied, elevated levels of adipsin, lipocalin-2, resistin, IL-6 and IL-17a can serve as potential biomarkers indicating a high probability of developing early hypertension in people under 45 years of age. Systolic and diastolic blood pressure levels also increase with an increase in waist circumference.
- 3 July 2024
- Published by The Institute of Internal and Preventive Medicine in Ateroscleroz
- Vol. 20 (2)
Abdominal obesity and levels of inflammatory markers and adipokines in young people with hypertension
Objective: to investigate pro- and anti-inflammatory markers and blood adipokines in young people with arterial hypertension (AH) on the background of abdominal obesity (AO). Materials and methods. 510 people were included in the study, of which 257 people with hypertension, of which 164 were with AO. In the control group (without AH) there were 253 people of comparable gender and age, with AO – 101 people. The content of adipsin, lipocalin-2, resistin, TNF-α, IL-6, IL-8, IL-10, IL-17a, IL-17e, IL-17f was determined in all blood by multiplex analysis. Statistical processing was carried out in the SPSS 13.0 program. Results. When comparing the studied parameters in the studied groups, statistically significant differences were obtained for lipocalin-2, resistin, adipsin, IL-6 and IL-17a, all these indicators were higher in the group with hypertension. There was no difference between the control and the group with hypertension in other biomarkers. There was no effect of AO on the level of the studied markers in the control group. For the main group, the difference between the subgroups with and without AO was obtained for lipocalin. Also, the systolic pressure level was significantly higher in the group with AO. Correlation analysis revealed a weak association of systolic and diastolic blood pressure with TNF-α, IL-6, adipsin, lipocalin-2, resistin and waist circumference. the association of body mass index with lipocalin-2, IL-6 and TNF-α (p < 0.01), a strong association of adipsin, lipocalin-2, resistin with TNF-α and IL-17a (p < 0.01). Conclusion. Of the markers we studied, elevated levels of adipsin, lipocalin-2, resistin, IL-6 and IL-17a can serve as potential biomarkers indicating a high probability of developing early hypertension in people under 45 years of age. Systolic and diastolic blood pressure levels also increase with an increase in waist circumference.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 27 (7)
Prevalence of therapeutic diseases depending on cytokines/chemokines levels in people under 45 years
Cytokines/chemokines profiles characterizing the body’s response to disease are not still investigated despite the numerous studies. Objective. To examine the distribution of therapeutic diseases in young people of working and childbearing age depending on levels of some cytokines/chemokines. Material and methods. The study included 1340 subjects aged 25—44 years. The levels of interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-alpha (TNF-α) and their associations with some therapeutic diseases, namely hypercholesterolemia, low-density lipoproteins, coronary heart disease, type 2 diabetes mellitus, arterial hypertension, renal dysfunction, chronic bronchitis, were determined by multiplex analysis method. Results. The highest incidence of therapeutic diseases was found at an increased IL-6 level. The prevalence of renal dysfunction is associated with high IL-6 and TNF-α values, arterial hypertension is more common at high IL-6 values. The chance of having renal dysfunction is associated with TNF-α equal more than 7.26 pg/ml (OR=3.282; 95% CI 1.330— 3.951; p<0.003). The chance of having arterial hypertension increases 4 times in the third quartile of IL-6 level compared to the first (OR=3.799; 95% CI 1.531—9.428; p=0.004) and remains in the fourth — IL-6 (OR=4.037; 95% CI 1.622—10.046; p=0.003). Conclusion. The highest incidence of therapeutic diseases was found at increased IL-6 level. The distribution of renal dysfunction is associated with high IL-6 and TNF-α values, arterial hypertension is more common at high IL-6 values.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 27 (7)
Prevalence of therapeutic diseases depending on cytokines/chemokines levels in people under 45 years
Cytokines/chemokines profiles characterizing the body’s response to disease are not still investigated despite the numerous studies. Objective. To examine the distribution of therapeutic diseases in young people of working and childbearing age depending on levels of some cytokines/chemokines. Material and methods. The study included 1340 subjects aged 25—44 years. The levels of interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-alpha (TNF-α) and their associations with some therapeutic diseases, namely hypercholesterolemia, low-density lipoproteins, coronary heart disease, type 2 diabetes mellitus, arterial hypertension, renal dysfunction, chronic bronchitis, were determined by multiplex analysis method. Results. The highest incidence of therapeutic diseases was found at an increased IL-6 level. The prevalence of renal dysfunction is associated with high IL-6 and TNF-α values, arterial hypertension is more common at high IL-6 values. The chance of having renal dysfunction is associated with TNF-α equal more than 7.26 pg/ml (OR=3.282; 95% CI 1.330— 3.951; p<0.003). The chance of having arterial hypertension increases 4 times in the third quartile of IL-6 level compared to the first (OR=3.799; 95% CI 1.531—9.428; p=0.004) and remains in the fourth — IL-6 (OR=4.037; 95% CI 1.622—10.046; p=0.003). Conclusion. The highest incidence of therapeutic diseases was found at increased IL-6 level. The distribution of renal dysfunction is associated with high IL-6 and TNF-α values, arterial hypertension is more common at high IL-6 values.
- Open Access
- 5 December 2023
- Published by APO Society of Specialists in Heart Failure in Kardiologiia
- Vol. 63 (11) , 4-11
Metabolic Blood Hormones in Young People With Electrocardiographic Signs of Ischemic Myocardial Changes
Aim To study changes in blood concentrations of metabolic hormones and adipocytokines in people aged 25-44 years with electrocardiographic (ECG) signs of ischemic changes in the myocardium. Material and methods This study was a part of a cross-sectional survey of a random sample of Novosibirsk population aged 25-44 years. The study included 1363 people divided into two groups: group 1, subjects with ECG signs of ischemic changes in the myocardium and group 2, subjects without ECG changes. Blood serum concentrations of adipocytokines and metabolic hormones were measured by multiplex assay on a Luminex MAGPIX flow-through fluorometer. Results The group with ECG signs of myocardial ischemia had higher blood concentrations of adiponectin, resistin, glucagon, and interleukin 6 (IL-6) than in the comparison group. A multivariate logistic regression analysis showed that the glucagon concentration was associated with the presence of ECG signs of myocardial ischemia (OR, 1.019; CI, 1.018-1.034; p=0.017). Conclusion In young people aged 25-44 years, higher blood concentrations of glucagon are associated with the presence of ECG signs of myocardial ischemia.
- 5 December 2023
- Published by APO Society of Specialists in Heart Failure in Kardiologiia
- Vol. 63 (11) , 4-11
Open AccessMetabolic Blood Hormones in Young People With Electrocardiographic Signs of Ischemic Myocardial Changes
Aim To study changes in blood concentrations of metabolic hormones and adipocytokines in people aged 25-44 years with electrocardiographic (ECG) signs of ischemic changes in the myocardium. Material and methods This study was a part of a cross-sectional survey of a random sample of Novosibirsk population aged 25-44 years. The study included 1363 people divided into two groups: group 1, subjects with ECG signs of ischemic changes in the myocardium and group 2, subjects without ECG changes. Blood serum concentrations of adipocytokines and metabolic hormones were measured by multiplex assay on a Luminex MAGPIX flow-through fluorometer. Results The group with ECG signs of myocardial ischemia had higher blood concentrations of adiponectin, resistin, glucagon, and interleukin 6 (IL-6) than in the comparison group. A multivariate logistic regression analysis showed that the glucagon concentration was associated with the presence of ECG signs of myocardial ischemia (OR, 1.019; CI, 1.018-1.034; p=0.017). Conclusion In young people aged 25-44 years, higher blood concentrations of glucagon are associated with the presence of ECG signs of myocardial ischemia.
- Open Access
- 21 January 2023
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 21 (4) , 121-129-129
Study of associations of blood proteins with development of unstable atherosclerotic plaques in coronary arteries by quantitative proteomics
Aim. To study the associations of blood proteins with the presence of unstable atherosclerotic plaques in the arteries in patients with coronary artery disease using the quantitative proteomic analysis.Materials and methods. The study included patients with coronary artery disease (n = 40); the average age of patients was 58 ± 7 years. Material for the study was blood serum. Protein concentrations in serum samples were determined using the PeptiQuant Plus Proteomics Kit (Cambridge Isotope Laboratories, USA). Protein fractions were identified using the liquid chromatograph and tandem mass spectrometer Q-TRAP 6500.Results. Mass spectrometry revealed an increased concentration of proteins, such as fibrinogen, fibulin-1, and complement factor H, in the serum samples of patients with unstable atherosclerotic plaques. It took place with a simultaneous decrease in the levels of α 2-antiplasmin, heparin cofactor II, coagulation factor XII, plasminogen, prothrombin, vitronectin, complement proteins (C1, C3, C7, C9), and complement factor B. The differences were considered significant at p < 0.05. It was revealed that the presence of unstable atherosclerotic plaques was associated with the level of fibulin-1 (Exp(B) = 1.008; р = 0.05), plasminogen (Exp(В) = 0.995; р = 0.027), and coagulation factor X (Exp(В) = 0.973; р = 0.037).Conclusion. An increased concentration of fibulin-1 can be considered as a potential biomarker of unstable atherosclerotic plaque development in coronary artery disease. The possibility of using the studied proteins as biomarkers of unstable atherosclerotic plaques requires further studies on their potential role in the development of this disease.
- 21 January 2023
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 21 (4) , 121-129-129
Open AccessStudy of associations of blood proteins with development of unstable atherosclerotic plaques in coronary arteries by quantitative proteomics
Aim. To study the associations of blood proteins with the presence of unstable atherosclerotic plaques in the arteries in patients with coronary artery disease using the quantitative proteomic analysis.Materials and methods. The study included patients with coronary artery disease (n = 40); the average age of patients was 58 ± 7 years. Material for the study was blood serum. Protein concentrations in serum samples were determined using the PeptiQuant Plus Proteomics Kit (Cambridge Isotope Laboratories, USA). Protein fractions were identified using the liquid chromatograph and tandem mass spectrometer Q-TRAP 6500.Results. Mass spectrometry revealed an increased concentration of proteins, such as fibrinogen, fibulin-1, and complement factor H, in the serum samples of patients with unstable atherosclerotic plaques. It took place with a simultaneous decrease in the levels of α 2-antiplasmin, heparin cofactor II, coagulation factor XII, plasminogen, prothrombin, vitronectin, complement proteins (C1, C3, C7, C9), and complement factor B. The differences were considered significant at p < 0.05. It was revealed that the presence of unstable atherosclerotic plaques was associated with the level of fibulin-1 (Exp(B) = 1.008; р = 0.05), plasminogen (Exp(В) = 0.995; р = 0.027), and coagulation factor X (Exp(В) = 0.973; р = 0.037).Conclusion. An increased concentration of fibulin-1 can be considered as a potential biomarker of unstable atherosclerotic plaque development in coronary artery disease. The possibility of using the studied proteins as biomarkers of unstable atherosclerotic plaques requires further studies on their potential role in the development of this disease.
- Open Access
- 30 November 2022
- Published by APO Society of Specialists in Heart Failure in Kardiologiia
- Vol. 62 (11) , 63-70
Associations of adipokines and metabolic hormones with low-density lipoprotein hypercholesterolemia in men and women under 45 years of age
Aim To study the adipokine profile in young people with hypercholesterolemia and low-density lipoproteins (LDL) and to evaluate the relationship between concentrations of LDL cholesterol (LDL-C) and metabolic hormones in men and women younger than 45 years. Material and methods This study included 304 subjects (group 1, 56 men with LDL-C concentration Results The groups differed in traditional cardiometabolic risk factors. In the male and female patient groups with LDL-C ≥4.2 mmol/l, the prevalence of impaired fasting glucose, incidence of insulin resistance, TG, and TC were higher than in subjects with LDL-C Conclusion Increased concentrations of LDL-C in young people were associated with changes in the adipokine profile and with the presence of metabolic syndrome components. These results were confirmed by changes in blood concentrations of metabolic markers that characterize disorders of metabolic processes.
- 30 November 2022
- Published by APO Society of Specialists in Heart Failure in Kardiologiia
- Vol. 62 (11) , 63-70
Open AccessAssociations of adipokines and metabolic hormones with low-density lipoprotein hypercholesterolemia in men and women under 45 years of age
Aim To study the adipokine profile in young people with hypercholesterolemia and low-density lipoproteins (LDL) and to evaluate the relationship between concentrations of LDL cholesterol (LDL-C) and metabolic hormones in men and women younger than 45 years. Material and methods This study included 304 subjects (group 1, 56 men with LDL-C concentration Results The groups differed in traditional cardiometabolic risk factors. In the male and female patient groups with LDL-C ≥4.2 mmol/l, the prevalence of impaired fasting glucose, incidence of insulin resistance, TG, and TC were higher than in subjects with LDL-C Conclusion Increased concentrations of LDL-C in young people were associated with changes in the adipokine profile and with the presence of metabolic syndrome components. These results were confirmed by changes in blood concentrations of metabolic markers that characterize disorders of metabolic processes.
- Open Access
- 14 November 2022
- Published by Arterialnaya Gipertenziya in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
- Vol. 29 (1) , 51-57
The level of adipokines in young people with hypertension and abdominal obesity
Objective. To investigate the adipokine blood profile in young people with hypertension (HTN) and abdominal obesity (AO). Design and methods. In total. 530 people were included in the study, including 267 people with HTN, of which 169 had AO. In the control group (without HTN) there were 263 people comparable to the study group by gender and age. Among them there were 106 people with AO. The blood levels of adiponectin, adipsin, lipocalin-2, resistin and plasminogen activator inhibitor-1 (PAI-1) were determined in all examined patients by multiplex analysis. Statistical data processing was carried out with the use of SPSS 13.0 program. Results. The levels of adiponectin and lipocalin-2 were lower in the group of HTN patients by 1,46 (p < 0,01) and 1,14 times (p < 0,05), respectively. The level of adipsin in HTN patients was significantly higher (p < 0,01) by 19,14 % compared to the control. The levels of resistin and PAI- did not differ in the control group and the group with HTN. Adiponectin level was 1,35 times lower (p < 0,05) in the group with AO compared to those without AO, the other indicators did not differ in the AO group and controls. In the HTN group, higher levels of PAI-1 were found in the subgroup with AO. When comparing the subgroup without HTN and without AO with the subgroup with HTN and AO, a significant decrease in concentration of adiponectin and lipocalin-2 was found. For the subgroups with AO, a decrease in adiponectin levels and an increase in adipsin levels (p < 0,01) were found in HTN patients. No statistically significant difference was found for the remaining indicators. The relative chance of early onset HTN was associated with the decrease in adiponectin and lipocalin-2 levels, and with the increase in adipsin levels, regardless of gender, age and the presence of AO. Conclusions. Thus, an increased level of adipsin and a reduced level of adiponectin and lipocalin-2 can serve as potential biomarkers indicating a high probability of developing early HTN in people under 45 years of age.
- 14 November 2022
- Published by Arterialnaya Gipertenziya in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
- Vol. 29 (1) , 51-57
Open AccessThe level of adipokines in young people with hypertension and abdominal obesity
Objective. To investigate the adipokine blood profile in young people with hypertension (HTN) and abdominal obesity (AO). Design and methods. In total. 530 people were included in the study, including 267 people with HTN, of which 169 had AO. In the control group (without HTN) there were 263 people comparable to the study group by gender and age. Among them there were 106 people with AO. The blood levels of adiponectin, adipsin, lipocalin-2, resistin and plasminogen activator inhibitor-1 (PAI-1) were determined in all examined patients by multiplex analysis. Statistical data processing was carried out with the use of SPSS 13.0 program. Results. The levels of adiponectin and lipocalin-2 were lower in the group of HTN patients by 1,46 (p < 0,01) and 1,14 times (p < 0,05), respectively. The level of adipsin in HTN patients was significantly higher (p < 0,01) by 19,14 % compared to the control. The levels of resistin and PAI- did not differ in the control group and the group with HTN. Adiponectin level was 1,35 times lower (p < 0,05) in the group with AO compared to those without AO, the other indicators did not differ in the AO group and controls. In the HTN group, higher levels of PAI-1 were found in the subgroup with AO. When comparing the subgroup without HTN and without AO with the subgroup with HTN and AO, a significant decrease in concentration of adiponectin and lipocalin-2 was found. For the subgroups with AO, a decrease in adiponectin levels and an increase in adipsin levels (p < 0,01) were found in HTN patients. No statistically significant difference was found for the remaining indicators. The relative chance of early onset HTN was associated with the decrease in adiponectin and lipocalin-2 levels, and with the increase in adipsin levels, regardless of gender, age and the presence of AO. Conclusions. Thus, an increased level of adipsin and a reduced level of adiponectin and lipocalin-2 can serve as potential biomarkers indicating a high probability of developing early HTN in people under 45 years of age.
- Open Access
- 24 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (21) , 12795
The Search for Associations of Serum Proteins with the Presence of Unstable Atherosclerotic Plaque in Coronary Atherosclerosis
To study the associations of blood proteins with the presence of unstable atherosclerotic plaques in the arteries of patients with coronary atherosclerosis using quantitative proteomics. The studies involved two groups of men with coronary atherosclerosis (group 1 (St) had only stable atherosclerotic plaques; group 2 (Ns) had only unstable atherosclerotic plaques, according to histological analysis of tissue samples); the average age of patients was 57.95 ± 7.22. Protein concentrations in serum samples were determined using the PeptiQuant Plus Proteomics Kit. The identification of protein fractions was carried out by monitoring multiple reactions on a Q-TRAP 6500 mass spectrometer combined with a liquid chromatograph. Mass spectrometric identification revealed in serum samples from patients with unstable atherosclerotic plaques a reduced concentration of proteins in the blood: α-1-acid glycoprotein, α-1-antichymotrypsin, α-1-antitrypsin, ceruloplasmin, hemopexin, haptoglobin, apolipoprotein B-100, apolipoprotein L1, afamin and complement component (C3, C7, C9). Moreover, at the same time a high concentration complements factor H and attractin. The differences were considered significant at p < 0.05. It was found that the instability of atherosclerotic plaques is associated with the concentration of proteins: afamin, attractin, components of the complement system, hemopexin and haptoglobin. The data of our study showed the association of some blood proteins with the instability of atherosclerotic plaques in coronary atherosclerosis. Their potential role in the development of this disease and the possibility of using the studied proteins as biomarkers requires further research.
- 24 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (21) , 12795
Open AccessThe Search for Associations of Serum Proteins with the Presence of Unstable Atherosclerotic Plaque in Coronary Atherosclerosis
To study the associations of blood proteins with the presence of unstable atherosclerotic plaques in the arteries of patients with coronary atherosclerosis using quantitative proteomics. The studies involved two groups of men with coronary atherosclerosis (group 1 (St) had only stable atherosclerotic plaques; group 2 (Ns) had only unstable atherosclerotic plaques, according to histological analysis of tissue samples); the average age of patients was 57.95 ± 7.22. Protein concentrations in serum samples were determined using the PeptiQuant Plus Proteomics Kit. The identification of protein fractions was carried out by monitoring multiple reactions on a Q-TRAP 6500 mass spectrometer combined with a liquid chromatograph. Mass spectrometric identification revealed in serum samples from patients with unstable atherosclerotic plaques a reduced concentration of proteins in the blood: α-1-acid glycoprotein, α-1-antichymotrypsin, α-1-antitrypsin, ceruloplasmin, hemopexin, haptoglobin, apolipoprotein B-100, apolipoprotein L1, afamin and complement component (C3, C7, C9). Moreover, at the same time a high concentration complements factor H and attractin. The differences were considered significant at p < 0.05. It was found that the instability of atherosclerotic plaques is associated with the concentration of proteins: afamin, attractin, components of the complement system, hemopexin and haptoglobin. The data of our study showed the association of some blood proteins with the instability of atherosclerotic plaques in coronary atherosclerosis. Their potential role in the development of this disease and the possibility of using the studied proteins as biomarkers requires further research.
- 1 January 2021
- Published by Russian Vrach, Publishing House Ltd. in Молекулярная медицина
- Vol. 19 (5) , 58-64
A comparison of the protein composition from coronary atherosclerotic plaque at different stages of development
- 1 January 2021
- Published by Russian Vrach, Publishing House Ltd. in Молекулярная медицина
- Vol. 19 (5) , 58-64
A comparison of the protein composition from coronary atherosclerotic plaque at different stages of development